Option Care Health reported second quarter 2026 financial results with net revenue of $1,442 million, a 1.9% increase year-over-year. GAAP diluted earnings per share rose 12.9% to $0.35, while adjusted diluted EPS increased 9.8% to $0.45. Adjusted EBITDA grew 3.0% to $117.5 million, and operating cash flow was $184 million. The company repurchased $150 million of shares during the quarter. Management updated full-year guidance, projecting net revenue between $5.675 billion and $5.775 billion, adjusted diluted EPS of $1.85 to $1.92, and adjusted EBITDA of $480 million to $495 million. Option Care Health is the nation’s largest independent provider of home and alternate site infusion services.